These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17985963)

  • 1. Clinically important improvement in the intensity of fatigue in patients with advanced cancer.
    Reddy S; Bruera E; Pace E; Zhang K; Reyes-Gibby CC
    J Palliat Med; 2007 Oct; 10(5):1068-75. PubMed ID: 17985963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report.
    Yennurajalingam S; Reddy A; Tannir NM; Chisholm GB; Lee RT; Lopez G; Escalante CP; Manzullo EF; Frisbee Hume S; Williams JL; Cohen L; Bruera E
    Integr Cancer Ther; 2015 Sep; 14(5):419-27. PubMed ID: 25873296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-related fatigue among patients with advanced cancer receiving immune-checkpoint inhibitors: a prospective study.
    Yennurajalingam S; Thomas L; Stanton PA; Lu Z; de Moraes AR; Bruera E
    Support Care Cancer; 2024 Jun; 32(7):459. PubMed ID: 38918253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.
    Yennurajalingam S; Frisbee-Hume S; Palmer JL; Delgado-Guay MO; Bull J; Phan AT; Tannir NM; Litton JK; Reddy A; Hui D; Dalal S; Massie L; Reddy SK; Bruera E
    J Clin Oncol; 2013 Sep; 31(25):3076-82. PubMed ID: 23897970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported sleep disturbance in patients with advanced cancer: Frequency, intensity, and factors associated with response to outpatient supportive care consultation--A preliminary report.
    Yennurajalingam S; Chisholm G; Palla SL; Holmes H; Reuben JM; Bruera E
    Palliat Support Care; 2015 Apr; 13(2):135-43. PubMed ID: 24182896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
    J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial.
    Zimmermann C; Swami N; Krzyzanowska M; Hannon B; Leighl N; Oza A; Moore M; Rydall A; Rodin G; Tannock I; Donner A; Lo C
    Lancet; 2014 May; 383(9930):1721-30. PubMed ID: 24559581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E; El Osta B; Valero V; Driver LC; Pei BL; Shen L; Poulter VA; Palmer JL
    J Clin Oncol; 2007 Aug; 25(23):3475-81. PubMed ID: 17687152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with response to methylphenidate in advanced cancer patients.
    Yennurajalingam S; Palmer JL; Chacko R; Bruera E
    Oncologist; 2011; 16(2):246-53. PubMed ID: 21282671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life measures in routine clinical care: can FACT-fatigue help to assess the management of fatigue in cancer patients?
    Santana MJ; Au HJ; Dharma-Wardene M; Hewitt JD; Dupere D; Hanson J; Ghosh S; Feeny D
    Int J Technol Assess Health Care; 2009 Jan; 25(1):90-6. PubMed ID: 19126256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.
    Yamaguchi T; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2016 Feb; 51(2):292-7. PubMed ID: 26598039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue in Patients With Advanced Terminal Cancer Correlates With Inflammation, Poor Quality of Life and Sleep, and Anxiety/Depression.
    Rodrigues AR; Trufelli DC; Fonseca F; de Paula LC; Giglio AD
    Am J Hosp Palliat Care; 2016 Dec; 33(10):942-947. PubMed ID: 26324072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal clinically important differences in the Edmonton symptom assessment system in patients with advanced cancer.
    Bedard G; Zeng L; Zhang L; Lauzon N; Holden L; Tsao M; Danjoux C; Barnes E; Sahgal A; Poon M; Chow E
    J Pain Symptom Manage; 2013 Aug; 46(2):192-200. PubMed ID: 23177724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between fatigue and other cancer-related symptoms in patients with advanced cancer.
    Yennurajalingam S; Palmer JL; Zhang T; Poulter V; Bruera E
    Support Care Cancer; 2008 Oct; 16(10):1125-30. PubMed ID: 18504622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Chinese patients receiving maintenance dialysis.
    Wang SY; Zang XY; Liu JD; Gao M; Cheng M; Zhao Y
    J Pain Symptom Manage; 2015 Jan; 49(1):135-43. PubMed ID: 24878068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
    Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
    J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.
    Tinsley A; Macklin EA; Korzenik JR; Sands BE
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1328-36. PubMed ID: 21999576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.
    Hui D; Shamieh O; Paiva CE; Khamash O; Perez-Cruz PE; Kwon JH; Muckaden MA; Park M; Arthur J; Bruera E
    J Pain Symptom Manage; 2016 Feb; 51(2):262-9. PubMed ID: 26482223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What does the answer mean? A qualitative study of how palliative cancer patients interpret and respond to the Edmonton Symptom Assessment System.
    Bergh I; Kvalem IL; Aass N; Hjermstad MJ
    Palliat Med; 2011 Oct; 25(7):716-24. PubMed ID: 21248179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could Objective Tests Be Used to Measure Fatigue in Patients With Advanced Cancer?
    Schvartsman G; Park M; Liu DD; Yennu S; Bruera E; Hui D
    J Pain Symptom Manage; 2017 Aug; 54(2):237-244. PubMed ID: 28063860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.